Mike Brock > Kirkland & Ellis LLP > Washington DC, United States > Lawyer Profile
Kirkland & Ellis LLP Offices

1301 Pennsylvania Avenue, N.W.
Washington, D.C., 20004
DISTRICT OF COLUMBIA
United States
- Firm Profile
- Go to...
Mike Brock

Position
Robert “Mike” Brock is a nationally recognized trial lawyer with 25 years of experience handling high-stakes, bet-the-business litigation. His practice focuses on representing pharmaceuticals and life sciences companies, particularly in product liability and mass tort cases. He has tried cases in a wide range of areas and has represented clients in antitrust, malpractice, toxic tort and securities class action litigation, as well as in other types of cases. Mike is a fellow of the American College of Trial Lawyers.
Mike has represented companies in some of the most high-stakes litigation in recent history. He currently serves as lead trial lawyer for BP in the Deepwater Horizon oil spill litigation. His trial performance has been highly praised and widely reported in the press. According to the Financial Times, one legal professional said that “in a courtroom full of top-tier legal talent,” Mike was particularly impressive, delivering “one of the most methodical and skillful cross-examinations I have seen” in 25 years.
Mike has also been exceptionally successful in his representations of leading pharmaceutical companies in product liability cases. He secured jury verdicts for Merck in a Fosamax® case in New York City and for AstraZeneca in its first Seroquel® lawsuit in New Brunswick, NJ. He also served as lead trial counsel to Merck in several Vioxx® cases, securing wins in Alabama, California, Florida and New Jersey. Recently, he has served as lead trial counsel for Pfizer in its Chantix® litigation and for Boehringer Ingelheim in litigation concerning Pradaxa®.
Mike is recognized by various legal publications as a first-class trial lawyer in products liability and mass tort litigation. He has been selected as a “leading lawyer” by Chambers USA, America’s Leading Lawyers for Business every year since 2009 and the current edition describes him as “a seasoned trial lawyer who boasts impressive experience representing a range of defendants in high-stakes product liability trials.” Sources for the guide say he is “one of the elite trial lawyers in the U.S.” with a “great courtroom presence” and an ability to “take complex issues and break them down in a way that’s accessible and understandable” and is “a first-rate first-chair trial lawyer” who “is front and center” in major disputes. He was also listed in the 2015–2023 editions of Chambers Global, The World’s Leading Lawyers for Business. The Legal 500 U.S. selected Mike to the “Hall of Fame” in 2021 and as a “leading lawyer” in 2014, 2015, 2018, 2019, 2020, and 2022 for Product Liability, Mass Tort and Class Action: Pharmaceuticals and Medical Devices, and singled him out as a “renowned trial lawyer.” He is also recognized by Legal 500 for Energy: Litigation and by Benchmark Litigation as a “National Star.”
Prior to joining Kirkland, Mike was a partner at Covington & Burling LLP, where he was the chair of their product liability and mass torts practice.
Lawyer Rankings
United States > Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
Recognized as being the ‘epitome of creative lawyering’, Kirkland & Ellis LLP‘s practice is centered around its Chicago and Washington DC offices, and is particularly noted for its trial skills, regularly acting in bellwether trials and dispositive motions. Renee Smith is ‘superb at trying cases across a range of products’, regularly prevailing in jury trials and multiple federal MDLs. Robert Ellis is a ‘top-notch litigator’ who regularly defends high-profile companies in complex consumer fraud and product liability class actions. Washington DC-based Mike Brock has vast experience in product liability cases and is a key member of the team, which also includes Mark Filip, who splits his time between Chicago and Washington DC and excels in handling matters involving governmental investigations or enforcement issues.
United States > Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
(Hall of Fame)Combining first-chair trial skills, alongside deep subject knowledge and procedural expertise, Kirkland & Ellis LLP is a popular choice among many leading life sciences companies to defend them against high-stakes product liability disputes throughout the country. Many of these take the form of MDLs/class actions, with the firm excelling in taking on leadership roles as national co-ordinating counsel, as well as handling key hearings – where it shines at explaining complex scientific issues to juries. The firm’s longstanding relationship with Abbott Laboratories recently saw it representing the Chicago-based medical device company in an MDL stemming from allegations regarding its recalled baby formula sickened infants. The firm has also had a key role in the sprawling opiate litigation on behalf of Allergan and continues to defend it against ongoing claims by hundreds of private and public entities that opted out of the recent global settlement. Washington DC-based Mike Brock is ‘a superb trial lawyer across product lines’ and remains particularly active in the life sciences space. Brock is a key member of the team along with Washington DC-based Jennifer Levy and Donna Welch in Chicago, with all three having a key role in the aforementioned Allergan matter.
United States > Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
‘The best of the best for mass tort litigation’, Kirkland & Ellis LLP regularly has a fulcrum role in class actions and MDLs in major environmental and toxic tort disputes throughout the country. Recognized as the ‘epitome of creative lawyering’, the team, which is more generalist than many in the ranking, has an excellent perspective throughout the litigation continuum, using its feared trial lawyers as effective leveraging tools to achieve beneficial settlements for clients, as well as being dogged and effective advocates in federal and state courts throughout the country. Washington DC-based litigator Mike Brock is a distinguished advocate whose versatile practice has included some high-profile environmental and toxic tort mandates; he continues to act as lead trial lawyer for BP in ongoing cases emanating from the Deepwater Horizon oil spill. Other recommended lawyers include Chicago-based litigators Renee Smith, Leslie Smith, and Donna Welch, all of whom have experience advising manufacturers and life sciences clients in toxic tort matters.
United States > Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport
With a ‘deep bench of tenacious litigators’ at its disposal, many of which display an ‘exceptional breadth of expertise’, Kirkland & Ellis LLP is well-equipped to handle a wide range of product liability matters in state and federal litigation throughout the country. While being adept at handling all stages of the litigation process, the firm is particularly praised for its trial readiness, ensuring that clients receive a robust defense in the event of a trial but also favorable settlements. Chicago-based Mike Brock and Renee Smith are both ‘impressive trial lawyers’, whose subject matter versatility includes handling high-stakes auto-related product liability matters. Notably, Smith regularly represents GM in class actions and MDLs alleging damage caused by a range of product defects, including recently securing summary judgment putting an end to a class action and thousands of individual cases asserting that the auto manufacturer had conspired to install Volkswagen-type ‘defeat device’ software in hundreds of thousands of trucks.
Lawyer Rankings
- Hall of Fame United States > Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Product liability, mass tort and class action - defense: automotive/transport United States > Dispute resolution
- Product liability, mass tort and class action - defense: consumer products (including tobacco) United States > Dispute resolution
- Product liability, mass tort and class action - defense: pharmaceuticals and medical devices United States > Dispute resolution
- Product liability, mass tort and class action - defense: toxic tort United States > Dispute resolution
Top Tier Firm Rankings
- Media, technology and telecoms > Advertising and marketing: litigation
- Finance > Capital markets: high-yield debt offerings
- International trade and national security > CFIUS
- Antitrust > Civil litigation/class actions: defense
- Government > Government relations
- Intellectual property > Copyright
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy litigation: oil and gas
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- Environment > Environment: transactional
- Dispute resolution > General commercial disputes
- Tax > International tax
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: litigation (full coverage)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Real estate > Real estate
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Securities litigation: defense
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Intellectual property > Trademarks: litigation
- Tax > US taxes: non-contentious
Firm Rankings
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Antitrust > Cartel
- Energy > Energy regulation: electric power
- Antitrust > Merger control
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Media, technology and telecoms > Outsourcing
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (International Trade Commission)
- Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Real estate > Real estate investment trusts (REITs)
- Energy > Renewable/alternative power
- Government > State attorneys general
- Finance > Structured finance: securitization
- Tax > US taxes: contentious
- Dispute resolution > E-discovery
- Environment > Environment: litigation
- Dispute resolution > Financial services litigation
- Insurance > Insurance: non-contentious
- Media, technology and telecoms > Media and entertainment: litigation
- Media, technology and telecoms > Media and entertainment: transactional
- Finance > Project finance
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- International trade and national security > Customs, export controls and economic sanctions
- Energy > Energy regulation: oil and gas
- Healthcare > Life sciences
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- M&A/corporate and commercial > Shareholder activism